Follow
Ali Maleki
Ali Maleki
Department of Virology, Pasteur Institute of Iran, Tehran, Iran
Verified email at pasteur.ac.ir
Title
Cited by
Cited by
Year
The ins and outs of SARS-CoV-2 variants of concern (VOCs)
M Salehi-Vaziri, M Fazlalipour, SM Seyed Khorrami, K Azadmanesh, ...
Archives of virology 167 (2), 327-344, 2022
502022
Efficacy and safety of a protein-based SARS-CoV-2 vaccine: a randomized clinical trial
E Mostafavi, S Eybpoosh, M Karamouzian, M Khalili, S Haji-Maghsoudi, ...
JAMA Network Open 6 (5), e2310302-e2310302, 2023
192023
How Iran responded to expanding need for laboratory services for COVID-19?
M Salehi-Vaziri, A Arashkia, E Mostafavi, T Jalali, MH Pouriayevali, ...
Health Policy and Technology 10 (2), 100506, 2021
82021
Investigation of IL-2 and IFN-γ to EBV peptides in stimulated whole blood among multiple sclerosis patients and healthy individuals
N Rafiee, M Ravanshad, B Asadi, R Kianfar, A Maleki
Intervirology 64 (4), 203-208, 2021
52021
MicroRNA and Nonsense Transcripts as Putative Viral Evasion Mechanisms
AA Bakre, A Maleki, RA Tripp
Frontiers in Cellular and Infection Microbiology 9, 152, 2019
52019
Comparison of a Multiplex Real-Time PCR Technique with Oxford Nanopore Technologies Next-Generation Sequencing for Identification of SARS-CoV-2 Variants of Concern
SVM Ahmadi Z, Maleki A, Eybpoosh S, Fereydouni Z, Tavakoli M, Kashanian S ...
Intervirology 66 (1), 136–141, 2023
12023
Novel Mutations Associated with N-Gene Target Failure in SARS-COV-2 Genome in Iran, Case Series
A Maleki, Z Fereydouni, M Tavakoli, A Ezani, M Hosseini, AH Nemati, ...
Journal of Medical Microbiology and Infectious Diseases 10 (3), 141-145, 2022
12022
Evaluation of IL-1β and IL-6 Expression following EBNA-1 and BRLF-1 Peptide Treatment in Epstein-Barr Virus-Positive Multiple Sclerosis Patients
R Kianfar, M Ravanshad, MA Ghiass, N Rafiee, A Shayeghpour, A Maleki
Intervirology 65 (3), 144-150, 2022
12022
Sequential HCoV-HKU1 and SARS-CoV-2 Infections, a Case Report
A Maleki, MH Pouriayevali, M Tavakoli, Z Ahmadi, F Niknam Oskouei, ...
Journal of Medical Microbiology and Infectious Diseases 10 (2), 93-97, 2022
12022
Clinical and genomic evaluations of a persistent fatal SARS-CoV-2 infection in a goods syndrome patient: a case report
P Tabarsi, A Maleki, Z Abtahian, A Khabbaz, Z Fereydouni, J Rezaie, ...
BMC Infectious Diseases 24 (1), 216, 2024
2024
Epidemiological surveillance of respiratory viral infections in SARS-CoV-2-negative samples during COVID-19 pandemic in Iran
A Maleki, P Mehrbod, F Bokharaei-Salim, S Eybpoosh, M Tavakoli, ...
Virology Journal 20 (1), 296, 2023
2023
Role of Laboratory in Emerging Infectious Disease Control in Iran, Pasteur Institute of Iran, and national laboratory network
A Maleki, E Mostafavi, M Fazlalipour, M Salehi‐Vaziri
Influenza and Other Respiratory Viruses 17 (12), e13232, 2023
2023
Increase in RNASEL gene expression by miR-29-3p inhibitors in HEK293T cells.
A Maleki, M Ravanshad, F Kouhkan
Epidemiologie, Mikrobiologie, Imunologie: Casopis Spolecnosti pro …, 2020
2020
Effect of HCV Core Protein on Expression of α-SMA in Human Stellate Cell, LX-2 Cell Line
A Maleki, M Ravanshad, SY Hosseini, M Gholami
Pathobiology Research 18 (4), 71-78, 2016
2016
The system can't perform the operation now. Try again later.
Articles 1–14